STIFTELSEN INDUSTRILABORATORIET

Med forsøk i tankene - siden 1990 | ILab | Over 30 års erfaring

ILAB er et oppdragslaboratorium for forskning innen akvakultur. Vi holder til på Marineholmen i Bergen – verdens ledende marine klynge.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: RH
Reidar Handegård1965
Chairman of the board: CE
Carl Erik Arnesen1957
Years since formation: 30 years; since Feb 19, 1995
Type: Foundation
VAT registered: Yes
Number of employees: 30

Financials

Total operating income 2024: 53,226,432; NOK
Annual total result 2024: -1,811,345; NOK
Total equity 2024: 25,454,689; NOK

Last update: Aug 12, 2025

Management

Management / administration

Name	Role	Shares
RH Reidar Handegård 1965	Managing Director/CEO	-

Board

Name	Role	Shares
CE Carl Erik Arnesen 1957	Chairman	-
AM Aurora Margrethe Brønstad 1967	Deputy Chair	-
BV Bodil Valland Steinhaug 1975	Board Member	-
ØF Øyvind Frette 1962	Board Member	-
PA Per Arne Foshaug 1965	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
A APELTUN RÅD OG REGNSKAP AS	Accountant	-

Last update: May 25, 2024

Ownership

Shares owned by the STIFTELSEN INDUSTRILABORATORIET

Name	Share class	Total number of shares	Share
M MARINEHOLMEN RASLAB AS	Ordinary shares	200,353	100 %

Last update: Jun 2, 2025

Group structure

STIFTELSEN INDUSTRILABORATORIET
Total operating income 2024: NOK 53,226,432
Operating profit 2024: NOK 2,897,659
Employees: 30

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	53,226,432	53,584,673	48,394,614	45,791,055
Annual Total Result	-1,811,345	963,094	-1,661,426	2,058,228
Total assets	36,724,598	38,709,239	36,404,534	40,360,573
Total liabilities	11,269,909	11,443,205	10,101,594	12,396,208
Total equity	25,454,689	27,266,034	26,302,940	27,964,365

P&L

Year	2024	2023	2022	2021
Total operating income	53,226,432	53,584,673	48,394,614	45,791,055
Total operating costs	50,328,773	52,438,342	50,517,079	43,259,619
Operating result	2,897,659	1,146,331	-2,122,465	2,531,436
Financial income/costs	-3,847,630	287,304	105,907	204,028
Profit before tax	-949,971	1,433,635	-2,016,558	2,735,464
Total tax & extraordinary income/cost	861,374	470,541	-355,132	677,236
Annual Total Result	-1,811,345	963,094	-1,661,426	2,058,228

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	10,737,884	17,177,697	17,273,054	18,570,993
Total current assets	25,986,714	21,531,542	19,131,480	21,789,580
Total assets	36,724,598	38,709,239	36,404,534	40,360,573
Short term debt	11,269,909	11,443,205	10,101,594	12,396,208
Long term debt	0	0	0	0
Total liabilities	11,269,909	11,443,205	10,101,594	12,396,208
Contributed capital	750,000	750,000	750,000	750,000
Retained earnings	24,704,689	26,516,034	25,552,940	27,214,365
Total equity	25,454,689	27,266,034	26,302,940	27,964,365
Total equity and liabilities	36,724,598	38,709,239	36,404,534	40,360,573

STIFTELSEN INDUSTRILABORATORIET954 740 560